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Abstract Health care has become increasingly patient-centred and medical
guidelines are considered to be one of the instruments that contribute towards
making it so. We reviewed the literature to identify studies on this subject. Both
normative and empirical studies were analysed. Many studies recommend active
patient participation in the process of guideline development as the instrument to
make guidelines more patient-centred. This is done on the assumption that active
patient participation will enhance the quality of the guidelines. We found no
empirical evidence, however, to support this assumption. Moreover, the studies
show that patients experience several difﬁculties in the participation process, which
cannot solely be traced back to ﬂawed practices. Given this poor track record we
conclude that the plea to actively involve patients in the guideline development
process should be reconsidered.
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Introduction
Patient-centred medicine is one of the dominant paradigms if not the dominant
paradigm in modern health care systems. It focuses on patient participation at
different levels of decision-making. The paradigm is strongest in individual
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patient’s point of view and to his or her needs and preferences [5]. It is assumed that
patients and doctors engage in a process of shared decision-making. For example,
patients must be given all the information they need in order to choose between
treatment A and treatment B. Physicians should help patients in making these
decisions. Arguments in favour of patient-centred medicine are mainly principle
based since patient autonomy is considered a basic value, but they also have a
practical side; patient-centred medicine is assumed to improve adherence to
treatment recommendations [24]. According to Salmon and Hall [37, 38] the
scientiﬁc basis for the importance of choice and control is weak. They argue that the
discourse of patient empowerment became so strong partly because it offers
clinicians a perfect way to withdraw from areas of patient need that are problematic
for them, such as unexplained symptoms, chronic disease, and pain. Responsibility
for these complicated forms of illness are gladly transferred to the empowered
patient [37, 38]. Still even these sceptical authors, who do not applaud the recent
developments acknowledge that patient-centredness has become a dominant
paradigm in modern medicine.
The individual physician–patient level is not the only level of decision-making in
health care that is becoming more patient-centred. Increasingly, patient represen-
tatives, in the Netherlands often volunteers of patient organisations, are asked to
participate in decision-making at the macro level. They can voice their opinion on
the medical research agenda [9], evaluate health care laws and advise on national
policy [47] and contribute to medical guideline development. In this paper we will
focus on the latter. In the Netherlands, as in other countries, patient participation in
guideline development is becoming increasingly common. It was encouraged by the
Dutch government in 1995 [48]. In 2000, the Dutch Health Council, an important
domestic advisory body, proposed patient participation in the development of
guidelines [19]. Since then, organisations charged with guideline production in the
Netherlands have been trying to actively involve patients in the guideline
development process [50, 56, 57]. Earlier, this democratic approach had been
adopted by countries such as Australia and the United Kingdom and it is also found
in other countries [22, 35, 41, 51].
One of the items on the AGREE (Appraisal of Guideline Research and
Evaluation) instrument, a European checklist to assess the quality of professional
guidelines, stipulates that a high quality guideline should take patients’ preferences
into account [1]. But how should this be done? In this article we present a review of
the literature search we performed on patient participation in guideline development
with a view to answering the following question: What is the current state of the
debate and the current state of affairs regarding patient participation in guideline
development? After the Methods section, we ﬁrst describe the studies we found and
the arguments identiﬁed in the literature on this subject. Subsequently, we
concentrate on the studies that report on patient participation in guideline
development practice. In the Discussion we argue, on the basis of the literature,
that increasing active patient participation in guideline development is not as logical
a step towards patient-centred medicine as it may seem.
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To answer the research question we performed a literature search in Pubmed/
Medline, the Cochrane Library, Web of Science and the online contents on the
subject of patient participation in guideline development. The keywords used were:
patient participation guideline development (84 hits), consumer participation
guideline development (117 hits), patient involvement guideline development
(103 hits) and consumer involvement guideline development (121 hits). Out of a
total of 425, 86 hits seemed relevant to our research question on the basis of title and
abstract (double hits excluded), but after closer inspection only 20 articles remained.
Regrettably, we had to exclude studies and letters not written in either English or
Dutch. We also excluded studies that did not refer to patient participation in
guideline development in any way. We found additional publications by means of
the chain referral technique, i.e., by also examining the lists of references of the
studies selected. In addition, in the ‘grey’ literature including (commissioned)
research, advisory and experiential reports, we found evaluations and other research
reports on patient participation in guideline development. After close scrutiny of
these publications, we selected 22 studies thus bringing the total to 42.
The main, or very important focus, of 20 of the studies we selected was patient
participation in guideline development. Three studies dealt with patient participa-
tion in decision-making processes in general, including guideline development.
Seventeen articles dealt with guideline development processes in general, including
patient participation. The last two publications were reﬂections on evidence-based
practice and other popular concepts in health care in which guidelines, and patient
participation in guideline development, was one of the subjects discussed. An
overview of these articles is presented in Table 1. We performed a content analysis
on these articles which resulted in a preliminary analytical scheme after six articles,
which was reﬁned after analyzing the other studies. The deﬁnitive analysis scheme
consisted of the following subjects: (1) the nature of the study (empirical or not) (2)
the focus of the article (was patient participation the main focus of the article), (3)
the kind of guideline that was studied, (4) the arguments used for participation, (5)
the participation methods, (6) the difﬁculties encountered, (7) the added value of
participation and (8) the recommendations for the future.
Results
We categorised the studies into empirical studies that studied guideline development
in practice, and non-empirical studies. Of the empirical studies, several authors
speciﬁcally studied patient participation in guideline development. Van Wersch and
Eccles [51] compared different participation methods in clinical practice by means
of a number of case studies. Van Wersch and Van Den Akker [52] and Jarret and
PIU [25] interviewed chairpersons and patient representatives, who had participated
in guideline development groups, about their experiences. Lanza [27] reported on
her experiences with patient participation in a focus group and survey research.
Sieders [43], himself a patient representative in a development group, compiled his
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and documents his patient organisation had developed as input for the process. The
other empirical studies we found consisted of surveys amongst guideline developers
that included a question on their ideas on, or their practice of patient participation
[10, 22, 23]. Burgers et al. [7] analysed guidelines on oncology on quality criteria
including patient participation. Smolders et al. [45] did the same for guidelines on
depression. In addition, several authors did a survey on patient communication
preferences and compared these to the (draft) guidelines [8, 35, 40]. Goossensen
et al. [21] also conducted a survey on patient preferences, but in this case the
information was used in the guideline development process. Gandjour et al. [17]
studied a guideline development process. In this guideline attention was paid to the
stages in which patient preferences might be considered. Others performed case
studies of guideline development (groups) in which patient representatives
participated [15, 28–30, 34, 42, 55].
Table 1 Studies on patient participation in guideline development
Main or very important focus Not main focus
Nease and Owen (1994) [31] Articles on patient participation in decision-making
Bastian (1996) [3] Williamson (1998) [54]
Duff et al. (1996) [14] Crawford et al. (2002) [12]
Butow et al. (1996) [8] Nilsen et al. (2006) [32]
Schoﬁeld et al. (1997) [40] Articles on guideline development in general
Owens (1998) [33] Field et al. (1992) [16]
Bauchner et al. (1998) [4] Gilmore (1993) [20]
Saltman (1998) [39] Carter et al. (1995) [10]
Lanza et al. (2000) [27] Grilli et al. (1996) [23]
Van Wersch and Eccles (2001) [51] Eccles et al. (1996) [15]
Rankin et al. (2000) [35] Smallwood and Lapsley (1996) [44]
Kelson (2001) [26] McInnes et al. (2000) [29]
Rogers (2002) [36] Gandjour et al. (2001) [17]
Cavelaars et al. (2002) [11] Graham et al. (2003) [22]
Jarret et al. (2004) [25] Pagliari and Grimshaw (2002) [34]
Van Veenendaal et al. (2004) [50] Burgers et al. (2004) [7]
Goossensen et al. (2005) [21] Brainin et al. (2004) [6]
Van Wersch and Van Den Akker (2005) [52] Moreira et al. (2005) [30]
Schunemann et al. (2006) [41] Smolders and Braspenning (2005) [45]
Sieders (2006) [43] Lui et al. (2006) [28]
Wright et al. (2006) [55]
Schunemann et al. (2007) [42]
Articles on popular concepts in health care
Grol (2001) [24]
Swinkels et al. (2002) [46]
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using Randomized Controlled Trials (RCTs). One cannot very well imagine a
research set up of guideline development groups with and without patient
representatives, engaging in the exact same quest. Decision-making processes must
be studied in different ways, for example by doing case studies, surveys, interviews
and guideline analysis. Thus, the studies we found cannot be dismissed as
methodologically ﬂawed, many of them provide us with insights in complicated
processes.
The non-empirical articles, ﬁrst of all, consisted of literature reviews [4, 11, 12,
24, 32, 33, 41, 46]. Secondly, we found articles reﬂecting recommendations of
committees or guideline developers on how to best develop and implement
guidelines [6, 16, 26, 44, 50]. Two articles reﬂected on seminars that had been
organised to discuss guideline development [14, 20]. Then there were articles that
referred to some publications but that could best be categorised as statements of
opinion [3, 36, 39, 49]. Finally, Nease and Owens [31] searched the literature and
tested a model on the cost effectiveness of incorporating the preferences of
individual patients into clinical practice guidelines. An overview of the nature of the
studies is presented in Table 2.
Patients and Guidelines: The Ideas
Our literature search showed that patient involvement in guidelines became a
subject of interest from the early 1990s onwards. We identiﬁed two strands of
thought in the literature:
1. Authors who argued that it is important for patients to participate actively in the
guideline development process.
2. Authors who argued that guidelines should accommodate individual patient
preferences without seeking active patient participation in the guideline
development process.
We begin by discussing the focus on active participation of patients in guideline
development. It is argued that participation is a consequence of the increasing
importance of the consumer’s choice in health care as we pointed out in the
Introduction [3, 36]. The ﬁrst strand of thought pleading strongly for active
participation can be found in the articles by Bastian [3] and Duff et al. [14]. In 1996,
Duff et al. [14] reported that patient participation in guideline development had
indeed been put into practice from time to time, but not nearly enough. Both Bastian
[3] and Duff et al. [14] argued that patients should be involved actively in the
development process using different strategies such as co-opting consumer
representatives into the guideline development group, a literature search into
patient preferences, and community consultation. At this time other studies show
that there is little support for this amongst doctors and guideline developers,
however [10, 23]. Still, it is argued by Bastian and Duff et al. that a truly
collaborative approach should be taken and that this would enable patients to climb
Arnstein’s ladder of participation. Arnstein [2] developed a ladder of citizen
participation consisting of the rungs: manipulation, therapy (together
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123non-participation), informing, consultation, placation (together tokenism) and
partnership, delegated power, citizen control (together citizen power). Over the
years, similar versions of a ladder of participation have been developed including
one for patient participation in guideline development [50]. Other authors followed
the line of reasoning of Bastian and Duff using three sets of arguments for active
patient participation: improved quality, increased legitimacy and principle based
desirability (ideology). Nineteen provided arguments in favour of active patient
participation; all of them arguing that this would lead to better decision-making,
hence improved quality [3, 4, 7, 11, 12, 14, 21, 23, 24, 26, 29, 32, 36, 39, 46, 49–
52]. Because of their experience with health care services, patients supposedly have
additional knowledge over and above that of physicians and researchers. Hence,
their participation may lead to better health care. Integrating patient preferences into
the guidelines will make them more applicable to health care practice and, therefore,
the chance of implementing the guidelines is increased.
The second set of arguments claims that patient participation increases the
legitimacy of the guidelines, since all parties were involved and the process was
more open [3, 11, 12, 23, 32, 50, 52]. The third line of argument is principle based
[3, 11, 12, 21, 32, 36, 50, 52]. Authors put forward that patient participation is
important simply because it is the right thing to do. Patients are the ones affected
most by these decision-making processes and, therefore, it seems only fair that they
should have a say in the matter. Furthermore, patients’ participation could
contribute to their empowerment as well as induce social change and shift the
balance of power between the actors in the health care sector. Also, participation is
politically desirable because it encourages participative democracy.
In contrast to the ﬁrst strand of thought we found in the literature, the second
strand of thought emphasised the importance of devoting space to individual patient
preferences in the guidelines without seeking active patient participation in the
guideline development process. Owens [33] argued that since patients’ views about
the quality of life with speciﬁc states of health and consequently about their
preferred therapy can vary greatly, guidelines should not be written as if patients
were all the same. To increase the quality of the guidelines (their legitimacy,
acceptability and usefulness), guidelines should include recommendations on topics
on which patients’ preferences vary, specifying how doctors can help patients to
choose according to their preferences. Other authors supported this plea for devoting
space in the guidelines to accommodate individual patient preferences [17, 20, 31].
Thus, guidelines can help make the individual patient–doctor contact more patient-
centred, a paradigm that is, as we stated in the Introduction, very strong in modern
health care [5, 37, 38].
The ﬁrst strand of thought—active patient participation in the guideline
development process—has become dominant in the discussion on patient-centred
medicine with regard to guidelines (Table 3). Although a number of authors stressed
the importance of both active patient participation in the development process and
individual patient preferences, the latter argument has become rare in recent years.
Even though authors differ on how intensively and in what way it should be
achieved, most agree that patients should participate actively in the process. Since
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argument we concentrate on it in the following section.
Patient Participation in Guideline Development: Practice
Increasingly, patient participation is being put into practice. After a survey amongst
developers of 730 Canadian guidelines that were published between 1994 and 1999,
Table 3 Patients and guidelines
Room for individual
preference in guideline
Active patient participation in
guideline development
Room for both individual
preferences
and active participation in
guideline development
Gilmore (1993) [20]
Nease and Owens (1994) [31]
Owens (1998) [33]
Gandjour et al.
(2001) [17]
Carter et al. (1995)* [10]
Bastian (1996) [3]
Duff et al. (1996) [14]
Grilli et al. (1996) [23]
Eccles et al. (1996) [15]
Bauchner and Simpson (1998) [4]
Lanza (2000) [27]
Rankin et al. (2000) [35]
Grol (2001) [24]
Van Wersch and Eccles (2001) [51]
Kelson (2001) [26]
Graham et al. (2003) [22]
Swinkels et al. (2002) [46]
Cavelaars et al. (2002) [11]
Pagliari and Grimshaw (2002)* [34]
Crawford et al. (2002) [12]
Moreira (2005) [30]*
Burgers et al. (2004) [7]
Jarret and PIU (2004) [25]
Brainin et al. (2004) [6]
Van Veenendaal et al. (2004) [50]
Van Wersch and Van Den Akker
(2005) [52]
Smolders and Braspenning (2005)
[45]
Lui et al. (2006) [28]
Schunemann et al. (2006) [41]
Sieders (2006) [43]
Wright et al. (2006)* [55]
Nilsen et al. (2006) [32]
Schunemann et al. (2007) [42]
Field and Lohr (1992) [16]
Butow et al. (1996) [8]
Smallwood and Lapsley (1997)
[44]
Schoﬁeld et al. (1997) [41]
Saltman (1998) [39]
Williamson (1998) [54]
McInnes et al. (2000) [29]
Rogers (2002) [36]
Goossensen et al. (2005) [21]
* These studies report on active patient participation but do not express views on its desirability
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involved in the development committees. This number has increased steadily in
these years; 51% of the guidelines drawn up in 1998–1999 were developed with
patients participating in the committees.
The message conveyed by these articles and documents is that involving patients
in guideline development is a good thing. We did not ﬁnd any articles that opposed
patient involvement, although apparently doctors and guideline development
organisations did not always look forward to the idea [10, 23]. The articles that
did not speciﬁcally address the practice of participation did all advocate it, even
though Nilsen et al. [32] concluded on the basis of a systematic review on patient
participation in decision-making that there is a lack of research that reliably
investigates whether consumer involvement actually delivers what it is supposed to
(improved quality and legitimacy). Because of this lack of clear evidence authors
simply stated that they believe patient participation is important. Alternatively, they
referred to literature that showed that patients and health care professionals hold
different opinions on certain subjects and thus concluded that both parties ought to
have a say in guideline development. For instance, Bauchner and Simpson [4]
referred to a study that showed that parents and health care professionals think
differently on diagnostic testing and diagnostic error.
The lack of evidence for the claims made can be explained by the fact that patient
participation in guideline development was not the main focus of all these studies.
However, when reading the literature it also seems that the importance of patient
involvement in guideline development was considered self-evident. For instance,
Saltman [39] argued that clearly it is appropriate for consumers to be involved. That
it is considered self-evident is also demonstrated by the fact that several authors
stated as a matter of fact that patients had been involved in the guideline
development processes researched by them [28, 30, 34, 42, 55]. Graham et al. [22]
considered it a bad thing if patients had not been involved. This attitude can be
interpreted as a sign that patient participation has become standard practice.
We now take a closer look at the studies that do report on experience with patient
participation in practice. We concentrate on the participation methods that were
used, the effects of participation and the difﬁculties encountered in the process.
The literature mentions several methods of patient participation. One such
method is to carry out a survey into patient preferences on a certain subject at the
time of guideline development [21, 27, 35]. Apparently, such surveys are often not
feasible because of budgetary constraints [11]. Surveying patient preferences can, of
course, also be part of the literature search of the guideline development group in
the sense that the state of the art concerning patient preferences is distilled from the
literature rather than organising a fact-ﬁnding mission oneself. Such a literature
search is generally not considered a form of active patient participation in guideline
development. Other methods of active participation mentioned in the literature are
patient focus groups, in which insight can be gained on patient preferences which
can be used as input in the guideline development process. Patient participation can
also be put into practice by letting patient representatives give feedback on draft
guidelines. Another method is enrolling patient representatives in the guideline
development groups. The latter method is mentioned most in the literature.
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methods of participation in practice. They studied the following methods:
(i) co-opting a patient into the guideline development group,
(ii) organising a one-time focus group,
(iii) holding a workshop where patients came together four times, and
(iv) co-opting a professional patient advocate into the development group.
The authors studied these four methods through a series of case studies within the
North of England evidence-based guideline development program. The authors
came to the conclusion that overall the individual patients in the guideline
development groups have very little input. Patients contribute most on the subject of
patient education, although subsequently their contributions are not acted upon. In
the one-time focus group patients are most interested in patient education and self-
management. They also suggest ways of making guidelines better accessible to
laypersons. The patients in the focus group have difﬁculties with the medical
terminology and the authors questioned whether they understand scientiﬁc evidence
on cost-efﬁciency. The workshop method is resource intensive. In order for them to
understand the process patients are taught through role play how the guideline
development procedure works. They also put forward some suggestions to make the
guidelines better accessible to laypersons (changing colours, the use of strong/weak
evidence instead of A, B, C, D, using brand names, etc.). The patient advocate in the
group understands the terminology and can contribute to the process. However, she
is not herself a patient. The authors concluded that consumers should be involved in
all stages of guideline development by using several methods at once, and
supporting patients throughout the process. Other studies arrived at similar
conclusions. Authors usually observed a paucity of information on which methods
work best and that it is, therefore, desirable to use different methods at once [3, 11,
14, 25, 26, 36, 50, 51]. None of the studies concluded that this lack of evidence is a
reason to stop patient participation.
Patients’ experiences with participation vary. A study on the experiences of
patient representatives in development groups and chairpersons of these groups in
the British National Health Service (NHS) guideline development process, showed
that most of them look back on a positive experience [25]. Accounts of patient
representatives who do not evaluate their efforts as positive were also found [43,
52]. Sieders, a volunteer patient representative himself, advises other patients, who
might consider participation in a guideline development group, against doing so
[43].
Participation in Guideline Development: Not an Easy Task
Most authors argued in favour of patient participation in guideline development
because, supposedly, it increases the quality of the guidelines. There is, however,
little evidence in support of this supposition. Van Wersch and Eccles [51, p. 15]
even concluded that: ‘having involved consumers within the guideline development
process (…) did not necessarily alter the content of the guidelines’. Schunemann
et al. [42] concluded that the feedback of consumers on the WHO H5N1 virus
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methodological, basic science experts and country representatives, and there were
no additional outcomes identiﬁed. Patients’ contribution to the process is mostly on
issues of communication and patient education [12, 21, 25, 26, 29, 51, 52]. What
subsequently happens to their input and what it consists of exactly is not clear. After
a patient survey on the need for psychosocial care for breast cancer patients one
study concludes that the ﬁndings suggest that the draft guidelines adequately reﬂect
consumer opinions [35]. The article is not clear about patient participation in the
development of the draft guideline, so it is not possible to determine whether the
guideline’s ﬁtting contents were the result of patient input at an earlier stage. This
difﬁculty of assessing the contribution patients make to the decision-making process
is not only seen in guideline development but in other decision-making processes as
well [32]. It is interesting to note that in the descriptions of the participation process
in guideline development groups, studies concentrated on the question whether
patients are up to the task instead of concentrating on their contribution to the
content of the process. The general conclusion was that patients can participate
provided they are given proper support. For instance they should be trained to
perform the task and chairpersons of the development groups should make sure that
patients can deliver their input. The studies therefore conclude that certain
adjustments in the participation process are warranted for participation [11, 25, 26,
51, 52].
Nevertheless, several difﬁculties were identiﬁed that cut deeper. There is
uncertainty amongst participants about the goals of participation [27, 36, 51, 52] and
patients have difﬁculty following medical jargon and assessing technical medical
literature [11, 25, 26, 36, 41, 51, 52]. Several authors pointed out that as a
consequence the patients gave little input [15, 26, 30, 51, 52]. According to Eccles
et al. [15, p. 48] patients in the development group were ‘often non-participating
observers of technical discussion to which they could offer no input’. The
difﬁculties identiﬁed can lead to high selection standards for patient candidates. For
instance, one of the qualiﬁcations on the job description for a prospective member in
the guideline development group used by the National Institute for Health and
Clinical Excellence (NICE), part of the NHS and responsible for the development of
guidelines, is the ability to understand scientiﬁc articles [25]. If, however, only
highly educated patient representatives are recruited, how representative is the
patient input? Some studies acknowledged this problem [14, 21, 41]. For example,
Goossensen et al. [21] argued that with a patient representative in the development
group, the opinion of a small, articulate group is represented. Therefore, a survey of
patient preferences is proposed in addition to this form of participation.
Another difﬁculty that is encountered is the integration of patients’ experiential
knowledge in an otherwise evidence-based guideline [25, 45, 51, 52]. Sometimes
patients’ input is not taken seriously because it is not based on scientiﬁc evidence.
Van Wersch and Van Den Akker [52, p. 20] even concluded that patient
representatives felt that ‘experiential knowledge was not considered as knowledge
at all’. This could well lead to disappointment amongst the patient representatives
involved [43, 45, 52].
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is almost completely ignored in the literature. The guideline development
organisation has to invest a considerable amount of time and money. More
importantly, the process also requires a substantial amount of time and effort from
the patient representatives who participate in guideline development groups. A
volunteer patient representative in the guideline development group on eating
disorders in the Netherlands calculated that his efforts had cost him a total of
2,000 h. He had tried to adhere to the evidence-based medicine (EBM) structure of
the development process and had searched medical databases for publications. In
other words, he had become a full member of the group. Still, he felt that his
contribution was not taken seriously. The patient organisation he represented,
therefore, did not endorse the guideline [43].
These problems encountered in the practice of patient participation in guideline
development do not seem to be easily overcome by training or support of patients.
The Future
At the beginning of this debate it was argued that not much is known about the
contribution of patients in practice or what methods should be used [4, 14].
Presently, 10 years later, these questions still remain unanswered [32]. After
identifying the existing difﬁculties authors concluded that it is important to continue
the participation process and that it should, therefore, be improved and intensiﬁed.
Many authors argued that a combination of methods should be used, including
active participation, throughout the development process. Most authors concluded
that patient representatives should receive more guidance during the process. Patient
participants ought to be trained, prepared and educated to fulﬁl their task [11, 25,
26, 51, 52]. Moreover, further research is recommended on how to make a success
of the development process. Few if any authors argued for less intensive methods.
Except for Sieders [43], who advised patients against participating in a development
group, and Eccles et al. [15], who proposed, after having studied patients in action
in guideline development groups, that this is not the correct way to include patient
input. They argued for a focus group. Another study argued for a survey as a viable
alternative [35]. However, Cavelaars et al. [11] concluded that doing a survey at the
time of guideline development is very costly and not a plausible alternative for that
reason.
We conclude that most authors do not recommend less intensive patient
participation nor do they search for less active ways of incorporating patient
preferences.
Discussion
Creating room to accommodate patient input in guidelines has been a subject of
discussion since the 1990s. We identiﬁed two strands of thought in the early years of
the debate. The ﬁrst was to let patients actively participate in the process of guideline
development through the use of focus groups and surveys, but especially by
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include recommendations in the guidelines that specify the importance of attention to
individual patient preferences at the physician–patient level. The ﬁrst strand of
thought has become the dominant one in the debate. The most important argument in
its favour is that patient participation would improve the quality of the guidelines.
Other arguments are principle based or stressed the increased legitimacy of decision-
making.
Is Active Participation Patient-Centred?
Although the general consensus seems to be that patients should be involved in
guideline development, the added value of their participation has yet to be
established. When participation is studied in practice the conclusion is usually that
patients can participate provided they receive proper support. Apparently authors
assume that patients can be trained to become full members in a guideline
development group and therefore ought to be included. However, training and
supporting patients to be able to participate as full members in an EBM guideline
development process is a double edged sword; one can wonder whether this is the
right way to go forward. Patients who have been trained and supported become
fellow academics; they may no longer be able to contribute the experiential
knowledge for which they were asked to participate in the ﬁrst place. Patients who
were not properly trained do contribute this experiential knowledge, but studies
have shown that it is difﬁcult to incorporate this in EBM guidelines.
When empirical evidence for something (a treatment, a management strategy, a
decision-making process) is not found, two options may be considered. Firstly, it
could be argued that more research should be done and conditions should be
improved so as to make the proposed practice a success. Secondly, it could be
argued that it is time to explore other alternatives. The existing literature on patient
participation in guideline development proposes the ﬁrst option. We feel it is
important to broaden the debate and that is time to consider the second. In our view,
the results in the literature show that active participation in guideline development is
not the best way towards making health care more patient-centred.
We do not argue that patient preferences are not important. On the contrary,
patients who want to be involved in decisions about their health and health care
should be given the opportunity to do so, and guidelines can help to make this
possible. The other line of reasoning, room for individual patient preferences in the
guidelines, which has largely disappeared from the debate, could be reconsidered to
accomplish this. This should not be considered as a step backwards in patient-
centred medicine but rather as a way to best accomplishing it. Apart from the fact
that the use of active participation has yet to be established, there is even the
possibility that patient involvement in the guideline development process could
hamper patient-centred care at the individual level. When the suggestion is raised
that patient preferences have already been incorporated in the guidelines, the danger
is that this could become a reason for the users of the guidelines not to pay as much
attention to preferences at the individual level. A guideline based on active
participation of all actors involved becomes a consensus document from which it
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1 The methods used for
participation, such as co-opting a patient representative into the group, are supposed
to provide input regarding what ‘the patient’ with a particular disease or condition
prefers and what ‘the patient’ experiences. Consequently, the uniqueness of every
patient that is emphasised at physician–patient level is no longer reﬂected in the
guidelines. Furthermore, since the contribution of patients to this process has yet to
become clear the suggestion that patient preferences have already been incorporated
in the guidelines is even further off the mark.
Attention in the guidelines for individual patient preferences can be accom-
plished by including a separate section or chapter on patient–physician
communication the importance of which for patients was repeatedly stressed in
the literature [8, 40]. Recommendations can be given on how professionals could
best organise this process. As we saw earlier, these issues are also raised by patients
when they do contribute to the development process, implying that they already
recognise its importance. Since it is not clear what becomes of these suggestions
when they are raised by a patient in a group, we recommend attention be paid to this
subject in all guidelines. A special patient version of the guidelines might further
help individual patients in their decision-making process and should, therefore, be
made available to patients who want to be actively involved in their own care.
Research into patient preferences on these issues can still be used as input for the
guidelines. For instance, surveys, or other types of research, could be done to
determine the views of patients with a certain condition. If it is concluded that there
is a paucity of such studies, as is sometimes done in the literature, it should be
placed on the health research agenda.
Research into patient preferences can be used as evidence in the development
process, but it should still be made clear that this research merely serves as a general
overview of patient preferences and that it does not represent an individual patient’s
preferences. Professionals involved in the development process and who have the
necessary skills to perform such literature searches, can be trusted to take these
studies into account in their literature search. There is no compelling reason why
patient representatives should be trained to perform this task.
Other Reasons for Participation
The above argument is relevant whenever the stated goal of active participation is to
improve the quality of the guidelines. As we have seen, however, there are other
arguments in the debate in favour of active participation. Legitimacy, in the sense
that decisions are made in all openness with patients functioning as a kind of referee
so the participants keep their eyes on the ball, can be seen as an important goal.
Other arguments can also still apply. For instance, the normative argument that
patients should participate in health care decision-making since they are the ones
directly affected by it. Participation then becomes more of a goal in itself. One
1 Taking into account every possible argument in the development process other than medical evidence
will make deviation from these guidelines ever more difﬁcult. Other arguments that are already used are
cost-efﬁciency, safety, usability, organisational feasibility and judicial considerations [53].
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a process that is primarily supposed to improve the quality of the guidelines.
Democracy has many advantages. Nevertheless, ever since Plato, people interested
in the quality of decisions have argued that improving the quality of decisions is not
one of them. The democratic constitution of guidelines may be considered valuable
for other reasons. For example, it may be good for people to participate in decision-
making processes. De Tocqueville [13, p. 125] regarded the citizen jury as ‘‘one of
the most effective means that the society can use for the education of the people’’.
He saw jury duty not as something that would be beneﬁcial for improving the
quality of the judicial outcome, but as something that is good for educational
purposes: ‘‘I do not know if the jury is useful to those who are parties to lawsuits,
but I am certain that it is very useful to those who judge them.’’ (ibid. p. 125). In this
connection Gastil and Weiser [18] recently concluded that the jury promotes civic
engagement; not only do they ﬁnd that jury service spurs increased electoral
participation, but it also broadens civic engagement such as an increased tendency
to discuss public affairs and staying informed. These educational or empowerment
purposes could also be an argument for asking patients to participate in decision-
making processes. The group of people that is reached through the participation
process would be quite small compared to the number of people involved in a
citizen jury system. However, if patient participation in health care decision-making
were viewed as part of a larger tendency to include citizens in decision-making
processes, this would not be a problem. For some patients this empowerment could
be especially important because their condition makes it difﬁcult for them to work
and participation in health care decision-making can provide an important means
towards feeling useful again. Crawford et al. [12] concluded that patients’ self-
esteem improved as a result of their contributions. This could be considered a
legitimate reason to continue participation processes. However, if civic education
were the main reason to promote patient participation, certain participation methods
should not be continued. At present, some patient representatives are paid staff
members employed by a patient organisation, who have never experienced living
with the condition themselves. The civic education goal would be lost on such
participants.
Another principle based argument in favour of patient participation might be the
balance of power or checks and balances. Patients are dependent on health care
professionals, they are affected by their decisions, and hence one might argue that
their presence in each and every organisation or forum involved in health care
decision-making should be considered necessary as well as self-evident. Even if
their involvement does not change the content of the guidelines much, it could make
all parties in health care at least feel more like partners. When the principle based
desirability is a position generally adhered to, it could be concluded that it is
important to continue with active participation. However, then these arguments
should also be the ones used in the discussion. This could prevent disappointment
amongst participants who expect to have a great deal of inﬂuence on the content of
the guidelines or who want to fully understand the whole process but cannot. Apart
from this it would still be important to create room for individual patient preferences
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representatives patient preferences have already been taken care off.
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